Treatment for Intertrigo
For uncomplicated intertrigo, keep the affected skin folds dry and apply a barrier product containing zinc oxide or similar moisture-wicking agents; if secondary infection is present, add topical antifungals for candida or topical antibiotics for bacterial infection, with systemic therapy reserved for severe or resistant cases.
Initial Management Approach
The cornerstone of intertrigo treatment is addressing moisture and friction in skin folds 1. This requires:
- Identify and correct predisposing factors (obesity, diabetes, immunosuppression, poor hygiene)
- Implement structured skin fold care: Keep areas clean and thoroughly dry, especially after bathing or sweating
- Use moisture-wicking textiles within skin folds to reduce skin-on-skin friction and prevent moisture accumulation 1
Treatment Based on Infection Status
Uncomplicated Intertrigo (No Secondary Infection)
Barrier products are the mainstay of treatment 1. Options include:
- Zinc oxide-based preparations combined with panthenol, glycerin, and emollients 2
- Adsorbent lotions containing tapioca starch and plant-based oils 3
- These products showed significant reduction in erythema and pruritus within 15-30 days 2
Candidal Intertrigo
When candida is suspected or confirmed (look for satellite pustules, white exudate, or positive KOH prep):
- Topical nystatin or azole antifungals (clotrimazole, miconazole, ketoconazole) are first-line 4
- Apply twice daily until resolution, typically 2-4 weeks
- For recurrent or resistant cases: Consider systemic azoles (fluconazole) if predisposing immunosuppression or widespread infection 4
- Address intestinal colonization or periorificial candida infections in recurrent cases 4
Bacterial Intertrigo (Gram-Negative)
Gram-negative bacterial intertrigo presents with weeping, erosive, painful lesions and frequently involves Pseudomonas aeruginosa 5:
- Topical antibiotics appropriate for gram-negative organisms
- Associated eczema is common (52%) - consider adding topical corticosteroids 5
- Expect prolonged healing time (median 56-61 days) even with appropriate treatment 5
- Risk factors include psoriasis, local humidity, vascular disease, and history of multiple prior treatments 5
Role of Topical Corticosteroids
Low-potency topical corticosteroids (1% hydrocortisone) can be used for inflammatory intertrigo but with important caveats:
- Effective for reducing inflammation and pruritus 3
- Do NOT use if candidal infection is present or suspected - steroids will exacerbate fungal infections 3
- Safe when combined with barrier products in non-infected cases 3
- Consider for gram-negative bacterial intertrigo with associated eczema 5
Common Pitfalls to Avoid
- Don't use high-potency steroids in skin folds - risk of skin atrophy and worsening infection
- Don't treat empirically without assessing for secondary infection - candida and bacteria require different approaches
- Don't neglect predisposing factors - treatment will fail without addressing obesity, diabetes control, or hygiene 4
- Expect recurrence (7-21% relapse rate) - patient education on prevention is critical 5
When to Escalate Treatment
Consider systemic therapy for:
- Immunocompromised patients with candidal intertrigo 6
- Disseminated candidiasis (look for nodular skin lesions on trunk/extremities) 6
- Severe bacterial intertrigo with systemic signs
- Treatment-resistant cases despite appropriate topical therapy
The evidence base for intertrigo treatment remains limited, with most recommendations based on low-quality evidence and clinical experience 1. However, the approach of moisture control, barrier protection, and targeted antimicrobial therapy when infection is present represents consensus among experts.